Cochrane Collaboration CAM Field: Resource for Research

Cochrane Collaboration是一个国际性、非营利性和独立的组织，致力于 通过准备、维持和促进可获得性，改善世界人口的医疗保健 系统评价。CAM现场是Cochrane协作中的指定小组，重点是 促进对补充医学和替代医学进行Cochrane系统审查 治疗。CAM领域是在综合医学中心内并由 马里兰大学自1996年成立以来，在布莱恩·伯曼的领导下，共同 CAM领域的创始人和召集人。 在过去的四年中，通过NCCAM提供的R24赠款支持了CAM领域。《CAM》 外地利用R24资金，通过协调以下工作，大大推进了NCCAM的重点和目标 准备高质量的CAM系统评价，改进CAM系统的研究方法 审查行为，开发一个专门的CAM RCT数据库，并广泛传播信息 关于系统评价、基于证据的CAM和Cochrane协作，向CAM研究人员， 从业者、普通民众和政策制定者。然而，仍有许多问题有待回答。 关于CAM疗法的有效性和安全性，仍有许多工作要完成 严格收集、评估和传播CAM中的高质量信息。 为了扩大CAM领域作为研究资源，制定了以下四个具体目标 对于这项拟议的R24资金续期：1)增加高质量系统审查的数量 CAM；2)加大对Cochrane CAM领域的推广力度；3)完善和增加数据库 CAM干预的随机对照试验；以及4)确保有效和高效的沟通 CAM现场成员和Cochrane协作内其他实体的成员之间的联系。 由于对CAM疗法的兴趣和使用只在美国和世界范围内不断增加，系统评价 将继续对临床医生和患者至关重要，因为他们寻求以证据为基础的知情健康 关爱决定。自成立以来，CAM领域进行了与系统相关的有价值的研究 回顾，一直是世界医学界的研究资源，并为 在Cochrane国际协作中发挥重要的行政作用。计算机辅助制造的生产效率 由于研究基础设施和全球网络，这一领域在未来几年只会增加 在过去的四年里在它内部发展起来的。

The Cochrane Collaboration is an international, nonprofit, and independent organization dedicated to improving health care for the world's population by preparing, maintaining and promoting the accessibility of systematic reviews. The CAM Field is the designated group within the Cochrane Collaboration focused on facilitating the conduct of Cochrane systematic reviews of complementary and alternative medicine therapies. The CAM Field is based within and sponsored by the Center for Integrative Medicine at the University of Maryland, as it has been since inception in 1996, under the leadership of Brian Berman, co- founder and Convener of the CAM Field. Over the past four years the CAM Field has been supported through an R24 grant from NCCAM. The CAM Field has used the R24 funding to significantly further the priorities and goals of NCCAM by coordinating the preparation of high quality systematic reviews of CAM, improving research methods for CAM systematic review conduct, developing a specialized database of CAM RCTs, and widely disseminating information about systematic reviews, evidence-based CAM, and the Cochrane Collaboration, to CAM researchers, practitioners, the lay public, and policy-makers. However, many questions still remain to be answered regarding the effectiveness and safety of CAM therapies and much remains to be accomplished in the rigorous collection, evaluation, and dissemination of high quality information in CAM. To expand the CAM Field as a resource for research, the following four specific aims have been developed for this proposedrenewal of our R24 funding: 1) Increase the number of high quality systematic reviews in CAM; 2) Increase promotion of the Cochrane CAM Field; 3) Improve and increase the database of randomized controlledtrials of CAM interventions; and 4) Ensure effective and efficient communication between CAM Field members and members of other entities within the Cochrane Collaboration. As interest in and utilization of CAM therapies is only increasing in the US and worldwide, systematic reviews will continue to be essential to clinicians and patients as they seek to make informed, evidence-based health care decisions. Since its inception, the CAM Field has conducted valuable research related to systematic reviews, has served as a research resource for the worldwide medical community, and has served an important administrative role within the international Cochrane Collaboration. The productivity of the CAM Field will only increase in the coming years, due to the research infrastructure and worldwide network developed within it over the previous four years.